The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
165 jobs Number of planned job creations
Announcement Date
3 March 2008
Employment effect (start)
Foreseen end date
1 March 2013
Description
IVAX Pharmaceuticals has announced that it will create 165 jobs over the next five years in Waterford. The EUR 65 million investment will enable the Waterford pharmaceutical firm to more than double both its inhaler and tablet manufacturing capacity relating to the relief and prevention of asthma. The asthma products manufactured in Waterford are exported worldwide. The SIPTU trade union has described the investment as “a real vote of confidence in the skills and commitment of the existing workforce”. According to the union, “as IVAX Pharmaceuticals is a highly unionised plant, their expansion plans dispel the myth that unions are anathema to business. It proves that management and unions can work together”.
Eurofound (2008), IVAX Pharmaceuticals Ireland, Business expansion in Ireland, factsheet number 66368, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/66368.